DEAD-Box Helicase 4 (Ddx4) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Aug 28

PMID 32847044

Citations 2

Authors

Stella DOronzo

Erica Silvestris

Domenica Lovero

Paola Cafforio

Loren Duda

Gennaro Cormio

Angelo Paradiso

Raffaele Palmirotta

Franco Silvestris

Affiliations

Soon will be listed here.

Abstract

DEAD-Box Helicase 4 (Ddx4) ovarian stem cells are able to differentiate into several cell types under appropriate stimuli. Ddx4 expression has been correlated with poor prognosis of serous ovarian cancer (OC), while the potential role of Ddx4 cells in non-serous epithelial OC (NS-EOC) is almost unexplored. The aim of this study was to demonstrate the presence of Ddx4 cells in NS-EOC and investigate the effect of follicle-stimulating hormone (FSH) on this population. Increased Ddx4 expression was demonstrated in samples from patients with advanced NS-EOC, compared to those with early-stage disease. Under FSH stimulation, OC-derived Ddx4 cells differentiated into mesenchymal-like (ML) cells, able to deregulate genes involved in cell migration, invasiveness, stemness and chemoresistance in A2780 OC cells. This effect was primarily induced by ML-cells deriving from advanced NS-EOC, suggesting that a tumor-conditioned germ cell niche inhabits its microenvironment and is able to modulate, in a paracrine manner, tumor cell behavior through transcriptome modulation.

Citing Articles

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy.

Arna A, Patel H, Singh R, Vizeacoumar F, Kusalik A, Freywald A Front Oncol. 2023; 12:1087989.

PMID: 36761420 PMC: 9905851. DOI: 10.3389/fonc.2022.1087989.

DEAD-box helicase 27 enhances stem cell-like properties with poor prognosis in breast cancer.

Li S, Ma J, Zheng A, Song X, Chen S, Jin F J Transl Med. 2021; 19(1):334.

PMID: 34362383 PMC: 8344201. DOI: 10.1186/s12967-021-03011-0.

References

Johnson J, Canning J, Kaneko T, Pru J, Tilly J . Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428(6979):145-50. DOI: 10.1038/nature02316. View

Li J, Wang J, Yue H, Lu X . SNAI2 3'untranslated region promotes the invasion of ovarian cancer cells by inducing MARCKS expression. J Cancer. 2019; 10(11):2480-2487. PMC: 6584344. DOI: 10.7150/jca.29489. View

Liu M, Hu Q, Tu M, Wang X, Yang Z, Yang G . MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. J Exp Clin Cancer Res. 2018; 37(1):10. PMC: 5778693. DOI: 10.1186/s13046-017-0669-z. View

Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K . KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2016; 45(D1):D353-D361. PMC: 5210567. DOI: 10.1093/nar/gkw1092. View

Chen F, Oskay-Ozcelik G, Buhling K, Kopstein U, Mentze M, Lichtenegger W . Prognostic value of serum and ascites levels of estradiol, FSH, LH and prolactin in ovarian cancer. Anticancer Res. 2009; 29(5):1575-8. View

Hashimoto H, Sudo T, Mikami Y, Otani M, Takano M, Tsuda H . Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint. Gynecol Oncol. 2008; 111(2):312-9. DOI: 10.1016/j.ygyno.2008.08.014. View

Chung S, Kim S, Seo Y, Kim S, Lee J . Quantitative analysis of cell proliferation by a dye dilution assay: Application to cell lines and cocultures. Cytometry A. 2017; 91(7):704-712. DOI: 10.1002/cyto.a.23105. View

Han W, Zhang Y, Niu C, Guo J, Li J, Wei X . BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition. Cancer Lett. 2019; 445:45-56. DOI: 10.1016/j.canlet.2019.01.003. View

10.

Stimpfel M, Skutella T, Cvjeticanin B, Meznaric M, Dovc P, Novakovic S . Isolation, characterization and differentiation of cells expressing pluripotent/multipotent markers from adult human ovaries. Cell Tissue Res. 2013; 354(2):593-607. DOI: 10.1007/s00441-013-1677-8. View

11.

Perales-Puchalt A, Wojtak K, Duperret E, Yang X, Slager A, Yan J . Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models. Mol Ther. 2018; 27(2):314-325. PMC: 6369450. DOI: 10.1016/j.ymthe.2018.11.014. View

12.

Tao X, Zhao N, Jin H, Zhang Z, Liu Y, Wu J . FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3. Endocr Relat Cancer. 2013; 20(3):415-29. PMC: 3669658. DOI: 10.1530/ERC-12-0005. View

13.

Itamochi H, Kigawa J, Terakawa N . Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 2008; 99(4):653-8. PMC: 11158134. DOI: 10.1111/j.1349-7006.2008.00747.x. View

14.

Zuo Q, Wu W, Li X, Zhao L, Chen W . HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin. Oncol Rep. 2011; 27(3):819-24. DOI: 10.3892/or.2011.1553. View

15.

White Y, Woods D, Takai Y, Ishihara O, Seki H, Tilly J . Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med. 2012; 18(3):413-21. PMC: 3296965. DOI: 10.1038/nm.2669. View

16.

Palmirotta R, Silvestris E, DOronzo S, Cardascia A, Silvestris F . Ovarian cancer: Novel molecular aspects for clinical assessment. Crit Rev Oncol Hematol. 2017; 117:12-29. DOI: 10.1016/j.critrevonc.2017.06.007. View

17.

Khalil C, Moussa M, Azar A, Tawk J, Habbouche J, Salameh R . Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study. J Ovarian Res. 2019; 12(1):70. PMC: 6660927. DOI: 10.1186/s13048-019-0546-9. View

18.

Tourkova I, Witt M, Li L, Larrouture Q, Liu L, Luo J . Follicle stimulating hormone receptor in mesenchymal stem cells integrates effects of glycoprotein reproductive hormones. Ann N Y Acad Sci. 2014; 1335:100-9. PMC: 4289445. DOI: 10.1111/nyas.12502. View

19.

Liu X, Li Q, Zhou J, Zhang S . ATP-binding cassette transporter A7 accelerates epithelial-to-mesenchymal transition in ovarian cancer cells by upregulating the transforming growth factor-β signaling pathway. Oncol Lett. 2018; 16(5):5868-5874. PMC: 6176408. DOI: 10.3892/ol.2018.9366. View

20.

Zhou W, Sun W, Yung M, Dai S, Cai Y, Chen C . Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance. Oncogene. 2018; 37(29):3981-3997. PMC: 6054535. DOI: 10.1038/s41388-018-0238-8. View